Development of a table of standard costs for conducting Clinical Trials in Australia: final report

Date published: 1 February 2022

The Australian Government established the Clinical Trials Action Group (CTAG), in October 2009, to boost Australia’s profile as a preferred destination for conducting clinical trials. The CTAG report, containing 11 recommendations endorsed by the Australian Government, was released by Ministers Roxon and Carr in March, 2011 with a commitment to implementation. Recommendation C of that report requires that the Independent Hospital Pricing Authority (IHPA) be directed to develop a table of standard costs associated with conducting clinical trials in Australia.

Last updated: 25 Aug 2022
Is this page useful?

Help us improve your IHACPA experience.

We'd like to know more about your visit today

 

Was this page useful?
Describe your experience
Describe your experience
What sector do you represent?